SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016504-10-000018
Filing Date
2010-11-15
Accepted
2010-11-15 16:33:09
Documents
24
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 inb10q_20100930.htm 10-Q 226115
2 inb001.gif GRAPHIC 20532
3 inb002a.gif GRAPHIC 19428
4 inb002b.gif GRAPHIC 11648
5 inb003.gif GRAPHIC 14807
6 inb004a.gif GRAPHIC 24843
7 inb004b.gif GRAPHIC 18860
8 inb005.gif GRAPHIC 11541
9 inb006.gif GRAPHIC 8405
10 inb007.gif GRAPHIC 3810
11 inb008.gif GRAPHIC 4128
12 inb009.gif GRAPHIC 6180
13 inb010.gif GRAPHIC 5867
14 inb011.gif GRAPHIC 5884
15 inb012.gif GRAPHIC 8240
16 inb013.gif GRAPHIC 6003
17 inb014.gif GRAPHIC 9970
18 inb015.gif GRAPHIC 6047
19 inb016.gif GRAPHIC 7084
20 exhibit31_1.htm EX-31 14002
21 exhibit31_2.htm EX-31 13917
22 exhibit32_1.htm EX-32 6900
23 exhibit32_2.htm EX-32 6988
24 exhibit3_1.htm EX-3 60905
  Complete submission text file 0001016504-10-000018.txt   598779
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 101192953
SIC: 2834 Pharmaceutical Preparations